Cancer trials show photodynamic therapy in a good light
This article was originally published in Clinica
Executive Summary
Scotia Pharmaceuticals has announced further positive results from trials of photodynamic therapy (PDT) with its Foscan light-sensitive drug to treat advanced head and neck cancer.